Effects of the Antimicrobial Peptide LL-37 and Innate Effector Mechanisms in Colistin-Resistant Klebsiella pneumoniae With mgrB Insertions
BackgroundColistin is a polypeptide antibiotic drug that targets lipopolysaccharides in the outer membrane of Gram-negative bacteria. Inactivation of the mgrB-gene is a common mechanism behind colistin-resistance in Klebsiella pneumoniae (Kpn). Since colistin is a cyclic polypeptide, it may exhibit...
Main Authors: | Hissa M. Al-Farsi, Salma Al-Adwani, Sultan Ahmed, Carmen Vogt, Anoop T. Ambikan, Anna Leber, Amina Al-Jardani, Saleh Al-Azri, Zakariya Al-Muharmi, Muhammet S. Toprak, Christian G. Giske, Peter Bergman |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmicb.2019.02632/full |
Similar Items
-
MgrB variants in colistin-susceptible and colistin-resistant Klebsiella pneumoniae ST258
by: Béla Kocsis, et al.
Published: (2017-10-01) -
Modifications of mgrB instigate colistin resistance in poultry gut-isolates in Bangladesh
by: M.U.L. Urmi, et al.
Published: (2020-12-01) -
Clinical and molecular characteristics of carbapenem non-susceptible Escherichia coli: A nationwide survey from Oman.
by: Hissa M Al-Farsi, et al.
Published: (2020-01-01) -
MgrB Alterations Mediate Colistin Resistance in Klebsiella pneumoniae Isolates from Iran
by: Mehri Haeili, et al.
Published: (2017-12-01) -
L'evolució T'L > L·L > LL en català
by: Emili Casanova
Published: (2015-11-01)